Biotech
New Drug Fights Lung Disease, Gets Big Funding
A new company, Expedition Therapeutics, raises $115 million to test a drug for a serious lung disease.
Expedition Therapeutics moves closer to helping people with lung disease. The company secured $115 million. This money will help them test a new drug.
The drug targets COPD. This is a lung disease that makes breathing hard. Millions of people suffer from it.
Big investors support Expedition. Sanofi, a large drug company, is one of them. This funding shows trust in the new drug.
The money helps the drug enter Phase 2 trials. These trials check if the drug is safe and works well. This is a key step to bring new medicine to patients.
This news offers hope for many. A successful drug could change lives for those with COPD.
Source: FierceBiotech
#Biotech#Healthcare#Investment
More from Biotech
